Barely Significant
← all excerpts

What is the optimal fit-for-purpose design in an oncology first-in-human trial?: 3+3 vs. Bayesian logistic regression model.

Transl Clin Pharmacol · 2020 · PMC7136082 · PMID 32274376

1
hedged sentence
closest p
boldest claim

The sentences

may be significantno p-value reported
If an inexperienced trial team initiates the trial with insufficient preparation, the time needed for dose escalation may be significant and result in longer trial duration compared to 3+3. • The computer will decide what the next dose should be .

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.